In this 7-minute video interview, Yuri E. Nikiforov, M.D., Ph.D., discusses current genetic testing capabilities in thyroid cancer and how it is aiding diagnosis as well as the use of more individualized thyroid cancer patient care. Dr. Nikiforov is a pathologist at the University of Pittsburgh Medical Center, where he leads a research and clinical program that looks at genetic mechanisms of thyroid cancer. He notes that the Chernobyl nuclear accident influenced his career direction and decisions. Dr. Nikiforov is a ThyCa Medical Advisor.
Просмотров: 387 ThyCa: Thyroid Cancer Survivors' Association, Inc.
Published: December 6, 2012 Speaker: Erik K. Alexander, M.D., Erik K. Alexander, M.D., is an Endocrinologist at Dana Farber Cancer Institute and Brigham and Women’s Hospital, in Boston, Massachusetts. He is also Director of Medical Student Education at Dana Farber Cancer Institute. Dr. Alexander graduated from Northwestern University Medical School, followed by residency and fellowship at Brigham and Women’s Hospital. He participates in clinical research involving thyroid disease and pregnancy, and thyroid nodules & thyroid cancer. He maintains the largest U.S. registry of consecutive thyroid nodules evaluated and aspirated via a multidisciplinary approach, with data from over 6,000 consecutive patients with clinically relevant thyroid nodules. Most recently, Dr. Alexander has led a national, multi-center study validating the Afirma gene expression classifier for thyroid nodule evaluation. Moderator: Jan Halzel, Pharm.D. Jan Halzel, Pharm.D., is with Biogen Idec, biotechnology company. She is a co-moderator of ThyCa's Medullary Thyroid Cancer E-mail Support Group, has moderated ThyCa’s first nine webinars, and is also involved in developing Medullary Thyroid Cancer content on ThyCa's web site. She has also represented ThyCa at many medical association meetings. She earned her bachelor's degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa's Medical Advisory Council.
Просмотров: 1911 ThyCa: Thyroid Cancer Survivors' Association, Inc.
The Role of Genetic Testing in the Evaluation of Thyroid Nodules
Просмотров: 110 Radiology Video
In this segment, panelists discuss genetic testing and screening for patients with advanced medullary thyroid cancer, which potentially aids in both the clinical management of patients and the counseling of family members. For more from this discussion, visit http://www.onclive.com/peer-exchange/managing-mtc
Просмотров: 237 OncLiveTV
Nearly a quarter of patients with medullary thyroid cancer have a hereditary version of the disease that is related to MEN 2A, MEN 2B, or a familial MTC syndrome. In this segment, panelists explore the proper approaches to genetic testing and screening for these hereditary syndromes. This segment includes perspectives from moderator, Ezra Cohen, MD, and Steven I. Sherman, MD, R. Michael Tuttle, MD, and Lori J. Wirth, MD. For more from this discussion, visit http://www.onclive.com/peer-exchange/managing-mtc
Просмотров: 1030 OncLiveTV
What is thyroid cancer? Thyroid cancer is a type of cancer affecting the thyroid gland. Find more videos at http://osms.it/more. Hundreds of thousands of current & future clinicians learn by Osmosis. We have unparalleled tools and materials to prepare you to succeed in school, on board exams, and as a future clinician. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways, and more when you follow us on social media: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Our Vision: Everyone who cares for someone will learn by Osmosis. Our Mission: To empower the world’s clinicians and caregivers with the best learning experience possible. Learn more here: http://osms.it/mission Medical disclaimer: Knowledge Diffusion Inc (DBA Osmosis) does not provide medical advice. Osmosis and the content available on Osmosis's properties (Osmosis.org, YouTube, and other channels) do not provide a diagnosis or other recommendation for treatment and are not a substitute for the professional judgment of a healthcare professional in diagnosis and treatment of any person or animal. The determination of the need for medical services and the types of healthcare to be provided to a patient are decisions that should be made only by a physician or other licensed health care provider. Always seek the advice of a physician or other qualified healthcare provider with any questions you have regarding a medical condition.
Просмотров: 61808 Osmosis
When someone is diagnosed with thyroid cancer, they and their doctor have a tough decision to make. Current treatment guidelines allow for either complete thyroid removal or partial removal – and each has its risks and benefits. University of Pittsburgh School of Medicine scientists and doctors are embarking on the first-ever clinical trial to determine if the UPMC-developed molecular genetic test ThyroSeq could make that decision easier, while minimizing surgical complications and helping some patients avoid having to take medication every day to keep thyroid hormone levels in check. Read more: http://www.upmc.com/media/NewsReleases/2017/Pages/yip-thyroid.aspx.
Просмотров: 646 UPMC
For additional information visit http://www.cancerquest.org/steven-sherman-interview.html Dr. Steven Sherman is Naguib Samaan Distinguished Professor and Chair in the Department of Endocrine Neoplasia and Hormonal Disorders within the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center. Dr. Sherman's research focus is thyroid cancer. His work addresses a wide range of topics around care and treatment of thyroid cancer patients that include: the molecular biology of thyroid cancer, development of genetic tests for thyroid cancer, and the development of targeted therapies to treat the disease In this interview segment, Dr. Sherman gives his thoughts on what lies in the future of genetic testing for thyroid cancer. To learn more about cancer and watch additional interviews, please visit the CancerQuest website at http://www.cancerquest.org
Просмотров: 186 CancerQuest
I has been a long journey but we aren't out of hot water just yet. Here is a look at my one year cancer check up, radioactive iodine body scan ( that's the nuclear scan ) and results. Is this the first video you have seen ? Start from the beginning and watch through the whole playlist. A lot of your answers and concerns are likely to be answered. https://www.youtube.com/playlist?list=PLLwW4oFptdz5pn2JENsX8CGEC3RRNSUn2 This was my journey with Thyroid Cancer. I am not a medical professional. Diagnosed August 2016. Surgery November 2016. RAI Therapy March 2017 Vocal Cord Surgery May 2017 One Year Nuclear Scan May 2018 __________________ ** NEW ** Facebook Chat & Support Group put on by SMP. Select one or all of the links below to request to join each group. Thyroid Conscious : https://www.facebook.com/groups/ThyroidConscious/ Sparkle Me Pink Beauty Chat : https://www.facebook.com/groups/SparkleMePink/ Sparkle Me Fit : https://www.facebook.com/groups/SparkleMeFit/ __________________ Some of my favorite (health) related things : Teami Blends : (Skinny Tea and Detox Mask) use coupon code "SPARKLE18" to get 18% OFF your order https://share.teamiblends.com/x/sfkOqz Isagenix : (Dairy free protein, Dairy free protein bars, COFFEE 🙌🏻) https://SparkleMePink.isagenix.com/ Doterra Essential Oils : (Balance, Breathe and Clary Calm) http://mydoterra.com/sparklemepink ____________________ Be sure to stay connected with Sparkle Me Pink by SUBSCRIBING and Following me on : BLOG: http://www.sparklemepink.com FACEBOOK: http://www.facebook.com/SparkleMePink8 TWITTER: https://twitter.com/SparkleMePink8 PINTEREST: http://pinterest.com/SparkleMePink8 INSTAGRAM: http://instagram.com/SparkleMePink8 EMAIL: email@example.com __ Disclaimer/Disclosure: All opinions are that of my own. NOT a sponsored video. * This description includes referral / affiliate links. Thank you for supporting Sparkle Me Pink by using them :-) Hi, I am Michelle Marino from Sparkle Me Pink. I am a professional makeup lover with a passion for finding the best affordable beauty products and sharing them on the internet. Here on SMP you will find makeup tutorials, first impressions, real talk product reviews, beauty bargains and lifestyle. Which of course includes the craziness that is mom life. Come join our fun, bubbly and down to earth SMP community. To do so simply click the SUBSCRIBE button.
Просмотров: 862 Michelle Marino
Two new tests are hitting the market this spring that use a person's genetic code to accurately diagnose hard to find cancer cells. Don’t forget to SUBSCRIBE for daily videos: http://bit.ly/1ERsYqw **More info & videos below** For full episodes, check out http://www.njtvnews.org/ Facebook: http://www.facebook.com/njtvonline/ Twitter: http://www.twitter.com/njtvnews/ ----------------- NJTV News with Mary Alice Williams is a week-nightly news program on NJTV covering local New Jersey news as well as a multi-platform, local information source for New Jersey. Be sure to share with us your story ideas, feedback and tips about news in your neighborhood here: http://bit.ly/1GnSEtn NJTV News with Mary Alice Williams airs every weeknight at 6, 7:30 and 11 p.m. ET on NJTV. ----------------- More videos: Are tax incentives a way to keep businesses in New Jersey? http://youtu.be/vSxan83tFVk How much sleep should you be getting? http://youtu.be/VZKCCtQsPjk Christie Discusses Pension Reform During Town Hall: http://youtu.be/dtxkXoDJMkQ Tiny House Movement Seen as a Way to Increase Affordable Housing: http://youtu.be/dcc7XqK6M7s
Просмотров: 277 NJTV News
http://www.dailyrx.com/benign-thyroid-nodules-may-be-identified-gene-signature http://www.dailyrx.com/conditions/thyroid-cancer Scientists have uncovered a potential new test which may eventually help identify which abnormal growths are not cancerous in order to avoid unnecessary tests and surgery. Doctors don't know why abnormal growths called nodules, commonly show up on the thyroid. Determining which nodules are cancerous tumors has been hard. A gene signature test in development may result in fewer people having unnecessary procedures to diagnose thyroid cancer. Learn about all tests used to help treat your cancer. For dailyRxTV, I'm Erin White.
Просмотров: 45 dailyRx
Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.
Просмотров: 223 OncLiveTV
While its base is the same as currently used tests for thyroid cancer a new approach is looking to redefine the specificity and exclusivity to help patients get a better idea of their condition.
Просмотров: 118 MD Magazine
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,firstname.lastname@example.org, https://plus.google.com/communities/115462130054650919641?sqinv=VFJWaER0c2NCRl9ERzRjZWhxQmhzY09kVV84cjRn , ,https://plus.google.com/u/0/+AlexandrosGSfakianakis , https://www.youtube.com/channel/UCQH21WX8Qn5YSTKrlJ3OrmQ , https://www.youtube.com/channel/UCTREJHxB6yt4Gaqs4-mLzDA , https://twitter.com/g_orl?lang=el, https://www.instagram.com/alexandrossfakianakis/, Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules by Marina N. Nikiforova, Stephanie Mercurio, Abigail I. Wald, Michelle Barbi de Moura, Keith Callenberg, Lucas Santana-Santos, William E. Gooding, Linwah Yip, Robert L. Ferris, Yuri E. Nikiforov via Cancer BACKGROUND Molecular tests have clinical utility for thyroid nodules with indeterminate fine-needle aspiration (FNA) cytology, although their performance requires further improvement. This study evaluated the analytical performance of the newly created ThyroSeq v3 test. METHODS ThyroSeq v3 is a DNA- and RNA-based next-generation sequencing assay that analyzes 112 genes for a variety of genetic alterations, including point mutations, insertions/deletions, gene fusions, copy number alterations, and abnormal gene expression, and it uses a genomic classifier (GC) to separate malignant lesions from benign lesions. It was validated in 238 tissue samples and 175 FNA samples with known surgical follow-up. Analytical performance studies were conducted. RESULTS In the training tissue set of samples, ThyroSeq GC detected more than 100 genetic alterations, including BRAF, RAS, TERT, and DICER1 mutations, NTRK1/3, BRAF, and RET fusions, 22q loss, and gene expression alterations. GC cutoffs were established to distinguish cancer from benign nodules with 93.9% sensitivity, 89.4% specificity, and 92.1% accuracy. This correctly classified most papillary, follicular, and Hurthle cell lesions, medullary thyroid carcinomas, and parathyroid lesions. In the FNA validation set, the GC sensitivity was 98.0%, the specificity was 81.8%, and the accuracy was 90.9%. Analytical accuracy studies demonstrated a minimal required nucleic acid input of 2.5 ng, a 12% minimal acceptable tumor content, and reproducible test results under variable stress conditions. CONCLUSIONS The ThyroSeq v3 GC analyzes 5 different classes of molecular alterations and provides high accuracy for detecting all common types of thyroid cancer and parathyroid lesions. The analytical sensitivity, specificity, and robustness of the test have been successfully validated and indicate its suitability for clinical use. Cancer 2018. © 2018 American Cancer Society. - video upload powered by https://www.TunesToTube.com
Просмотров: 86 Alexandros G. Sfakianakis
This video is an informative animated presentation that explains in detail about Thyroid cancer and treatment . Thyroid cancer is a disease that begins in your thyroid gland. If you have thyroid cancer, it may be one of four types, depending on the type of thyroid cell in which the cancer started and the appearance of the cancer cells. Papillary carcinoma is the most common thyroid cancer and begins in follicular cells. Follicular carcinoma accounts for 1 in 10 cases and also begins in follicular cells. Medullary carcinoma is less common and starts para-follicular cells. Anaplastic thyroid carcinoma is a rare, more dangerous form of thyroid cancer. Thyroid cancer, like other cancers is an unrestrained growth of cells due to damaged genetic material in the cell’s nucleus. A tumour forms as the cells begin to accumulate. Overtime, a lump form in your thyroid as the tumour enlarges you may feel a lump in your neck over the thyroid gland. You may have neck or throat pain, coarseness and trouble swallowing as the tumour grows around the trachea. Watch the video to know more about types and treatment of thyroid cancer. Visit here for more details - http://manipalhospitals.com/diabetes-thyroid-care/ Best Hospital in India: Manipal Hospitals is one of the top multi-speciality hospital in India located at all major cities like Bangalore, Vijayawada, Visakhapatnam, Goa, Salem, Jaipur, Mangalore. Provides world class 24/7 Emergency services. Our top surgeons are expertise in offering best treatment for Heart, Brain, Cancer, Eye, Kidney, Joint replacement surgery & all major surgeries at affordable cost. Health Check-up packages are also available. To know more visit our website : https://www.manipalhospitals.com/ Get Connected Here: ================== Facebook: https://www.facebook.com/ManipalHospitalsIndia Google+: https://plus.google.com/111550660990613118698 Twitter: https://twitter.com/ManipalHealth Pinterest: https://in.pinterest.com/manipalhospital Linkedin: https://www.linkedin.com/company/manipal-hospital Instagram: https://www.instagram.com/manipalhospitals/ Foursquare: https://foursquare.com/manipalhealth Alexa: http://www.alexa.com/siteinfo/manipalhospitals.com Blog: https://www.manipalhospitals.com/blog/
Просмотров: 80471 Manipal Hospitals
Part of a weekly segment on Cancer and Genetics, CNN discusses previvors and genetic testing with Dr. Ora Karp Gordon, MD, MS. Dr. Gordon is Director of the GenRISK Adult Genetics Program and Genetics Director of the Wasserman Breast Cancer Risk Reduction Program. She also is a geneticist at the Saul and Joyce Brandman Breast Center and the Thyroid Cancer Center at Cedars-Sinai. She is an assistant clinical professor at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).
Просмотров: 1748 Lisa Marton
Published on September 24, 2012 Thyrogen (rhTSH), used in connection with testing and treatment of differentiated thyroid cancer (papillary, follicular, and their variants) Speaker: Bryan R. Haugen, M.D., Endocrinologist, University of Colorado Health Science Center, Denver, Colorado. Dr. Haugen is the President-Elect of the American Thyroid Association, to become ATA President in late September 2012, and is a ThyCa Medical Advisor. Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor Bryan R. Haugen, M.D., Endocrinologist, University of Colorado School of Medicine, is Professor of Medicine and Pathology, as well as Head, Division of Endocrinology, Metabolism & Diabetes, and Chair of Endocrine Neoplasms Research. Dr.Haugen's clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction, and other endocrine tumors. Dr Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets. Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms. His research group is also actively studying novel regulation of the hypothalamic-pituitary-thyroid axis.Dr. Haugen is President of the American Thyroid Association. He is a member of ThyCa's Medical Advisory Council. Moderator: Jan Halzel, Pharm.D. Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa's Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa's web site. She also represents ThyCa at medical association meetings. She earned her bachelor's degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa's Medical Advisory Council.
Просмотров: 2071 ThyCa: Thyroid Cancer Survivors' Association, Inc.
While watching an episode of The Doctors, one woman took a simple test that led to a shocking discovery: thyroid cancer. Subscribe to The Doctors: http://bit.ly/SubscribeTheDrs LIKE us on Facebook: http://bit.ly/FacebookTheDoctors Follow us on Twitter: http://bit.ly/TheDrsTwitter Follow us on Pinterest: http://bit.ly/PinterestTheDrs About The Doctors: The Doctors is an Emmy award-winning daytime talk show hosted by ER physician Dr. Travis Stork, plastic surgeon Dr. Andrew Ordon, OB-GYN Dr. Jennifer Ashton, urologist Dr. Jennifer Berman and family medicine physician and sexologist Dr. Rachael Ross. The Doctors helps you understand the latest health headlines, such as the ice bucket challenge for ALS and the Ebola outbreak; delivers exclusive interviews with celebrities dealing with health issues, such as Teen Mom star Farrah Abraham, reality stars Honey Boo Boo and Mama June and activist Chaz Bono; brings you debates about health and safety claims from agricultural company Monsanto and celebrities such as Jenny McCarthy; and shows you the latest gross viral videos and explains how you can avoid an emergency situation. The Doctors also features the News in 2:00 digest of the latest celebrity health news and The Doctors’ Prescription for simple steps to get active, combat stress, eat better and live healthier. Now in its eighth season, The Doctors celebrity guests have included Academy Award Winners Sally Field, Barbra Streisand, Jane Fonda, Marcia Gay Harden, Kathy Bates and Marisa Tomei; reality stars from Teen Mom and The Real Housewives, as well as Kris Jenner, Caitlyn Jenner, Melissa Rivers, Sharon Osbourne, Tim Gunn and Amber Rose; actors Jessica Alba, Christina Applegate, Julie Bowen, Patricia Heaton, Chevy Chase, Kristin Davis, Lou Ferrigno, Harrison Ford, Grace Gealey, Cedric the Entertainer, Valerie Harper, Debra Messing, Chris O’Donnell, Betty White, Linda Gray, Fran Drescher, Emmy Rossum, Roseanne Barr, Valerie Bertinelli, Suzanne Somers; athletes Magic Johnson, Apolo Ohno and Danica Patrick; musicians Tim McGraw, Justin Bieber, Clint Black, LL Cool J, Nick Carter, Kristin Chenoweth, Paula Abdul, Gloria Gaynor, La Toya Jackson, Barry Manilow, Bret Michaels, Gene Simmons and Jordin Sparks; and celebrity chefs Wolfgang Puck, Guy Fieri and Curtis Stone.
Просмотров: 52989 The Doctors
Traditionally, fine needle aspiration biopsy has been the accepted method for diagnosing thyroid cancer. However, in about 25 percent of patients this procedure cannot provide a definitive diagnosis. ThyroSeq® is a new test developed at UPMC using next-generation gene sequencing, examining biomarkers that may indicate cancer. Yuri Nikiforov, MD, PhD, director of Molecular and Anatomic Pathology at UPMC, led the team that developed this new test, and discusses how it can accurately diagnose potentially cancerous nodules, and may eliminate the need for suboptimal surgery.
Просмотров: 711 UPMC
I was first diagnosed with an underactive thyroid when I was 10 years old. This diagnosis wasn't too much of a surprise because many people on my mom's side of the family have thyroid issues. This past year, we had genetic testing done to see if I have a rare medical condition known as Cowden syndrome. This condition involves the PTEN gene and many people with this medical condition have thyroid issues/thyroid cancer. I love sharing my story, educating others on rare and complicated medical condition and connecting with others through sharing my story. Blog: https://kaitlynlife101.wordpress.com/ Cowden Syndrome website: https://ghr.nlm.nih.gov/condition/cowden-syndrome
Просмотров: 431 Kaitlyn Keely
Mount Sinai's Dr. Eric Genden addresses issues relatiing to genes and thyroid cancer, now and in the future. Dr. Genden is Chairman of the Department of Otolaryngology - Head and Neck Surgery at the Mount Sinai Health System and Professor of Otolaryngology - Head and Neck Surgery and Immunobiology. As Chief of the Division of Head and Neck Oncology, Dr. Genden is board certified in head and neck surgery and fellowship trained in head and neck oncology and microvascular reconstruction. His practice is centered on thyroid, parathyroid surgery, head and neck cancer surgery, and airway reconstruction. Dr. Genden is internationally recognized as a leader in head and neck cancer surgery, particularly as it relates to HPV, and head and neck microvascular reconstruction. Visit Dr. Eric Genden here, http://bit.ly/12YepBM and visit www.mountsinai.org/ent for more information.
Просмотров: 2163 Mount Sinai Health System
Thyroid Cancer Symptoms And Treatment,Thyroid Cancer Cause,Facts About Thyroid Cancer,Thyroid Cancer Thyroid cancer is the cancer in the tissues of thyroid glands. If diagnosed early, the thyroid cancer is the most treatable form of cancer. Thyroid Cancer: Symptoms Causes Diagnosis and Treatment, What are the early signs and symptoms of thyroid cancer?, Is thyroid cancer deadly?, How serious is thyroid cancer?, Can you survive with thyroid cancer?, Thyroid Cancer: Diagnosis Treatment and Prognosis, Thyroid cancer - Symptoms and causes, Types of Thyroid Cancer, Suffering from Thyroid Cancer, Thyroid Cancer Treatment, thyroid cancer causes, thyroid cancer treatment, thyroid cancer types, thyroid cancer stages, thyroid cancer survival rate, thyroid cancer prognosis, thyroid cancer symptoms in females, thyroid cancer diagnosis, Thyroid Cancer Treatment, Thyroid Cancer Symptoms Signs Treatment and Types, What is thyroid cancer?, Thyroid Cancer Facts Everyone Should Know, About thyroid cancer, Thyroid cancer symptoms & treatments, Types of thyroid cancer, Treating thyroid cancer, Overview of Thyroid Cancer, Warning Signs of Thyroid Cancer Thyroid cancer most common in women then men. It is found at the age of 40 to 50 in women, whereas 60 to 70 years in men. There are 4 types of thyroid cancer : 1. Papillary thyroid cancer 2. Follicular thyroid cancer, 3. Medullar thyroid cancer and 4. Anaplastic thyroid cancer. There will be no symptoms in early stage of thyroid cancer. There will be only few symptoms of thyroid cancer. The symptoms include - Neck pain, throat pain, difficulty in swallowing, Voice change and hoarseness, cough, A lump that can be felt through the skin on your neck and swollen lymph nodes in neck. The causes of thyroid cancer is not clear. But the few factors are inherited genetic syndrome, exposure to radiation, iodine deficiency. The thyroid cancer can be diagnosid with physical tests, genetic tests, biopsy, ultrasound, CT Scan, PET Scan. The treatments include surgery, hormone therapy, radioactive iodine, radiation and chemotherapy.
Просмотров: 50 Health Tips 365 Days
Yuri E. Nikiforov, MD, PhD, Director of the Division of Molecular Anatomic Pathology, Department of Pathology, University of Pittsburgh, discusses a study that examined pathological and molecular trends in thyroid cancer since 1973. For more information on biomarkers, visit http://www.targetedhc.com/targeted/biological-markers
Просмотров: 874 Targeted Oncology
VIDEO 1 Sonic Health Care USA CBLPath National Sales Meeting, March 13, 2018 Thyroid Nodules and Thyroid Cancer An Essential Primer for the Sales Team Presented by Dr. Bryan McIver, MD PhD 0:00:00 Thyroid Nodules and Thyroid Cancer, An Essential Primer 0:00:04 Intro by Heidi Gautier / McIver CV 0:01:32 Session Introduction 0:02:46 Intro to Thyroid Nodules and Thyroid Cancer 0:03:41 Sales Team Members' Role 0:05:59 It Starts With a Thyroid Nodule What Causes a Thyroid Nodule? 0:06:47 1. A Simple Cyst 0:07:10 Thyroid Structure 0:08:11 Thyroid Cyst 0:09:39 2. Autoimmune Thyroid Disease - Hashimoto’s 0:10:58 Hurthle Cells; Endocrinologist v. Pathologist view 0:12:20 3. Hyperplastic Nodule 0:13:35 Hyperplastic Nodule v. Neoplastic Nodule 0:15:20 The Trouble with Hyperplastic Nodules: suspicious for Follicular Neoplasm 0:16:32 4. Thyroid Follicular Adenoma 0:17:22 TSH-R Mutations and varying risks of malignancy 0:20:09 RAS Mutations 0:24:27 Not every mutation equals cancer: ThyroSeq & Early detection of mutations 0:25:10 Follicular Adenoma 0:26:18 Follicular Neoplasm 0:28:34 5. NIFT-P 0:30:54 premalignant nodules, Bethesda III or V 0:32:36 Encapsulated non-invasive Follicular-variant papillary thyroid carcinoma (FV-PTC) 0:33:20 ThyroSeq is a true positive molecular test indicating neoplasm 0:34:06 Risk of Malignancy: NIFT-P v FV-PTC 0:34:41 Molecular profiling allows tailored treatment that suits the risk 0:38:20 Past approaches to indeterminate cytology and thyroid cancers 0:38:47 ATA current guidelines, identifying the spectrum of risk 0:41:22 The consequences of the Veracyte binary classifier approach What Causes a Thyroid Nodule? (cont'd) 0:43:56 5. Cancer of the Thyroid - PTC, FTC, HCC, ATC 0:44:37 5% of thyroid cancers are medullary cancers (MTC) 0:44:49 ThyroSeq GC detection of Thyroid cancers 0:45:57 Prevalence of Thyroid Nodules in Women and Men 0:49:04 Thyroid Cancer Incidence and Prevalence Among other Cancer Types 0:50:28 Ultrasounds and FNA Biopsies 0:51:14 Number of Thyroid Fine Needle Biopsy (FNA) procedures on the rise 0:51:49 Increasing Discovery of Indolent Cancer 0:52:28 Ultrasound, FNA’s, Cytology and CPT codes 0:53:34 Management of Thyroid Cancers 1995-2010 0:54:52 Thyroid Carcinoma: The Spectrum of the Disease 0:55:32 Arguments for a Precision Approach 0:56:51 Defining Risk: The tumor-host relationship 0:57:05 Patient Factors Influencing Prognosis 0:57:44 Cause-Specific Mortality Rates in FCDC 0:59:10 AJCC/UICC Tumor Staging 0:59:37 VIIth Edition Staging for FTC, HCC, and PTC 1:00:38 PTC Survival by TNM Stage 1:00:38 Remember to Include Treatment Efficacy 1:01:56 Risk of Structural Disease Recurrence 1:02:53 Case 1 - ATA Recommendations 1:04:13 ATA Guidelines 1:07:06 Q: On the Importance of Using the Bethesda System 1:12:16 Q: On Responding to Questions about “False Negatives” 1:15:26 Q: ThyroSeq and the Future of Cytopathology 1:16:43 Q: ThyroSeq Screening and- Para-Thryroid Tissue and Metastatic Disease
Просмотров: 216 Ground and Vision
Thyroid cancers are made up of many genes that make searching for hereditary risk factors difficult. But a new James study is looking at a specific kind of thyroid cancer, called papillary thyroid cancer, to identify not only genetic risks, but parts of patients’ DNA that can lead to the disease. By recruiting people with at least three cases of papillary thyroid cancer in the family, James experts can provide a variety of genetic testing methods to look for genetic markers and hone in what is causing certain families to be at risk.
In this 12-minute video interview, R. Michael Tuttle, M.D., Endocrinologist at Memorial Sloan-Kettering Cancer Center in New York, New York, discusses several thyroid cancer topics. These include recent research on “watchful waiting” (also called active surveillance) rather than immediate surgery for small papillary or follicular thyroid cancers —under 1 centimeter in size. The interview also covers thyroid hormone replacement decision-making in thyroid cancer patients, as well as the issues of overdiagnosis and overtreatment. Dr. Tuttle is a thyroid cancer specialist, focusing on treatment of advanced thyroid cancer. He is a ThyCa Medical Advisor.
Просмотров: 791 ThyCa: Thyroid Cancer Survivors' Association, Inc.
Join UCLA endocrine surgeons Masha Livhits, MD, and Yasmine Assadipour, MD, for a conversation about the underlying risks for thyroid cancer. The discussion will cover genetic syndromes associated with thyroid cancer, environmental factors such as radiation exposure and other personal and lifestyle risks. Learn more: https://www.uclahealth.org/endocrine-center/thyroid-cancer #UCLAMDChat
Просмотров: 534 UCLA Health
Video abstract of case report paper “Thyroid cancer in a patient with Lynch syndrome – case report and literature review” published in the open access journal Therapeutics and Clinical Risk Management by authors Monika Fazekas-Lavu, Andrew Parker, Allan D Spigelman et al. Abstract: Lynch syndrome describes a familial cancer syndrome comprising germline mutations in one of four DNA mismatch repair genes, MLH1, MSH2, MSH6, and PMS2 and is characterized by colorectal, endometrial, and other epithelial malignancies. Thyroid cancer is not usually considered to be part of the constellation of Lynch syndrome cancers nor have Lynch syndrome tumor gene mutations been reported in thyroid malignancies. This study reports a woman with Lynch syndrome (colonic cancer and a DNA mismatch repair mutation in the MSH2 gene) with a synchronous papillary thyroid cancer. Six years later, she developed metachronous breast cancer. Metastatic bone disease developed after 3 years, and the disease burden was due to both breast and thyroid diseases. Despite multiple interventions for both metastatic breast and thyroid diseases, the patient’s metastatic burden progressed and she died of leptomeningeal metastatic disease. Two prior case reports suggested thyroid cancer may be an extraintestinal malignancy of the Lynch syndrome cancer group. Hence, this study examined the genetic relationship between the patient’s known Lynch syndrome and her thyroid cancer. The thyroid cancer tissue showed normal expression of MSH2, suggesting that the tumor was not due to the oncogenic mutation of Lynch syndrome, and molecular analysis confirmed BRAF V600E mutation. Although in this case the thyroid cancer was sporadic, it raises the importance of considering cancer genetics in familial cancer syndromes when other cancers do not fit the criteria of the syndrome. Careful documentation of other malignancies in patients with thyroid cancer and their families would assist in better understanding of any potential association. Appropriate genetic testing will clarify whether a common pathogenic mechanism links seemingly unrelated cancers. Read the full paper here: https://www.dovepress.com/thyroid-cancer-in-a-patient-with-lynch-syndrome-ndash-case-report-and--peer-reviewed-article-TCRM
Просмотров: 57 Dove Medical Press
The staging of a patient with medullary thyroid cancer is generally performed during the initial diagnosis. In this segment, panelists describe the optimal approaches required to adequately characterize the overall disease burden. To view more from this discussion, visit http://www.onclive.com/peer-exchange/managing-mtc
Просмотров: 1556 OncLiveTV
3841. NEW TEST TO DIAGNOSE THYROID CANCER: A new molecular testing panel greatly improves chances of additional surgeries that may require removal of the thyroid For contact information: http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=33918&channelid=CHAN-100005
Просмотров: 108 Ivanhoe Web
Thyroid Cancer, Surgery Day part 6. The day has finally come. Its been a long road, good days as well as some bad ones. Yet to know better days are ahead. Getting my story out, trying to help others. Getting yourself checked is the first step. Take the time for you, life is precious. Thank you all for the love and support. BLENDED CHAOS PO BOX 15416 FT WAYNE IN 46885
Просмотров: 31557 Blended Chaos
https://goo.gl/iIrBBH Thyroid Cancer Removal Surgery - Total Thyroidectomy by Dr Majid Ahmad Talikoti Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. Most often the first symptom of thyroid cancer is a nodule in the thyroid region of the neck. The most effective management of aggressive thyroid cancers is surgical removal of thyroid gland. The most effective management of aggressive thyroid cancers is surgical removal of thyroid gland (thyroidectomy) followed by radioactive iodine ablation and TSH-suppression therapy. Chemotherapy or radiotherapy may also be used in cases of distant metastases or advanced cancer stage. Eight-year survival rates. Signs and symptoms Most often the first symptom of thyroid cancer is a nodule in the thyroid region of the neck. However, many adults have small nodules in their thyroids, but typically under 5% of these nodules are found to be cancerous. Causes Thyroid cancers are thought to be related to a number of environmental and genetic predisposing factors, but significant uncertainty remains regarding its causes. Environmental exposure to ionizing radiation from both natural background sources and artificial sources is suspected to play a significant role, and there are significant increased rates of thyroid cancer in those exposed to mantlefield radiation for lymphoma. Diagnosis After a thyroid nodule is found during a physical examination, a referral to an endocrinologist or a thyroidologist may occur. Most commonly an ultrasound is performed to confirm the presence of a nodule and assess the status of the whole gland. https://en.wikipedia.org/wiki/Thyroid_cancer Join the Facebook Group https://www.facebook.com/groups/medfreelancers/ Subscribe YouTube Channel https://www.youtube.com/user/medfreelancers Contact details Mobile & WhatsApp No:- +91 9910580561 E-mail :- email@example.com Services available in Delhi and NCR Fluidscape by Kevin MacLeod is licensed under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100393 Artist: http://incompetech.com/ https://goo.gl/iIrBBH -~-~~-~~~-~~-~- Please watch: "Endoscopic Septoplasty for Correction of Deformity of Septum | ENT Surgery " https://www.youtube.com/watch?v=Hwi9LcD1HcY -~-~~-~~~-~~-~-
Просмотров: 9985 MedFreelancers
Thyroid nodules are very common especially in women. In this video, Dr. Roy discusses the thyroid nodule which has undergone a needle biopsy and is reported to be “suspicious for thyroid cancer”. This does not mean that you have a thyroid cancer. The actual risk of thyroid cancer may vary based upon how this diagnosis was made. If a genetic analysis of your thyroid nodule was used in order to arrive upon a diagnosis suspicious of thyroid cancer, then this information will be important to you as well as the expert thyroid cancer surgeon and endocrinologist who are caring for you. An expert ultrasound is critically important. Lymph nodes around the thyroid gland and in the sides of the neck should also be examined. Our thyroid nodule app can help you better understand your thyroid nodule which is suspicious for thyroid cancer and the next steps you should consider. You can access your free thyroid nodule app here: Free 3-D Thyroid Nodule app - http://www.thyroidcancer.com/app In this video, watch Dr. Roy discuss the thyroid nodule which is suspicious for malignancy. Dr. Rashmi Roy is one of the world’s most experienced thyroid surgeons. This is not an urgent or immediate matter. In almost all cases you have had this thyroid nodule for years, but have only just become aware of it. Don’t panic and don’t hurry into a thyroid surgery. Take time to educate yourself and to find the best endocrinologist and the best surgeon to manage your thyroid cancer.
Просмотров: 23 Clayman Thyroid Cancer Center
Thomas H. Covey, Jr., MD, Visiting Professor Lectureship
Просмотров: 47 WVU Surgery
Causes of thyroid cancer that you were not aware of The exact cause of thyroid cancer is not known. Similar to how other cancer forms develop, changes in the DNA of cells is responsible for the development of thyroid cancer. These alterations could either be genetically inherited or occur over a period of time. But, it is well established that cancer is not contagious. 1 Thyroid cancer risk factors Exposure to radiation increases one's chances of getting thyroid cancer. A mere dental X-ray, however, does not increase the chances of developing thyroid cancer, but a radiation therapy to the head, neck or chest surely does. There has been significant amount of research to understand DNA changes that become cancerous. Most cancers are not inherited, which means that DNA gets damaged by the exposure to something in the environment such as radiation or smoke during the course of one's life. The cancer may also occur when unexpected changes take place inside a cell without a specific external cause. The following are the prominent risk factors for thyroid cancer: 2 Benign thyroid disease Thyroid conditions i.e., either underactive or overactive thyroid are not related to the risk of thyroid cancer in any way, however, non-cancerous conditions such as nodules (adenomas), goitre (an enlarged thyroid) and thyroiditis (inflammation of the thyroid) increase thyroid cancer risk. 3 Radiation and low iodine levels Thyroid cancer is more likely to develop in individuals who have had radiotherapy treatments at a tender age, though the cancer usually develops years later. Survivors of atomic explosions or accidents are also at an increased risk of developing thyroid cancer. Individuals with low levels of iodine in their body are at more risk of thyroid cancer after any exposure to radiation. 4 Family history of thyroid cancer Individuals with a family history of thyroid cancer are at a higher risk of developing thyroid cancer. 5 Bowel condition FAP Familial adenomatous polyposis (FAP), a condition caused by an inherited gene, increases the chances of developing thyroid cancer. 6 Breast condition history Women with non-cancerous breast conditions are at increased risk of thyroid cancer. 7 Cancer history Individuals who have been treated for breast cancer, oesophageal cancer, testicular cancer or non Hodgkin's lymphoma have high risk of developing thyroid cancer. These are the possible risk factors for thyroid cancer suggested by research reports over the years. Although thyroid cancer is a rare form of cancer, it is favourable to be aware about its symptoms and treatment options for better prognosis. **************************** Top 7 Juices to Cure cancer https://www.youtube.com/watch?v=UZirAeQIy98 Papaya Leaves A Powerful Cure for Cancer | Natural Health https://www.youtube.com/watch?v=42iALmCnLOY Why Are Doctors Hiding This Simple Recipe - This Is How You Can Treat Bunions 100% Naturally https://www.youtube.com/watch?v=aa81e5hMq3w Coconut Oil and Baking Soda Can Destroy Cancer! Eye-opening evidence https://www.youtube.com/watch?v=CdHXiB2qvvQ The Top 27 Alkaline Foods On The Planet Eat More To Prevent Cancer Obesity And Heart Disease https://www.youtube.com/watch?v=yQRhyqNR3Io 20 ways never get cancer - part1 |Natural Health https://www.youtube.com/watch?v=4FkHMq6rxe8 Aronia Kills Cancer Cells Viruses and Slows Aging | Natural Health https://www.youtube.com/watch?v=3jcf0HVBUjA Cannabis And Coconut Oil Make Powerful Mixture To Kill Cancer Cells https://www.youtube.com/watch?v=NV_6V4F0HCk =========================================================== Thanks for watching! New videos posted daily! PLEASE SUBSCRIBE FOR USEFUL TIPS, TRICKS & TECHNIQUES TO IMPROVE YOUR LIFE! More information: Channel: https://goo.gl/cEH8QB Facebook: https://goo.gl/qAJYH8 Gplus: https://goo.gl/HBUJny
Просмотров: 4920 Natural Health
http://drlarsen.com/top-10-thyroid-tests-you-need/ Is your "thyroid panel" good enough? Most people we see have very inadequate lab work. There is more to it than just measuring TSH (thyroid stimulating hormone). DR. BRANT LARSEN, DC BIO: Dr. Larsen is a chiropractor who specializes in helping chronic condition patients get their lives back using functional nutrition, cellular healing, cellular detoxification, and neurologically based chiropractic. Conditions that have responded to Dr. Larsen’s Multi-Therapeutic Approach include: Weight loss resistance Autoimmune disorders Diabetes Digestive disorders Chronic fatigue Fibromyalgia Heart disease Thyroid disorders Allergies ADD/ADHD Sleep disorders Multiple chemical sensitivity (MCS) Hormone Imbalances Peripheral neuropathy Chronic pain Joint injuries Migraines and more. His private practice is located in Forest Lake, Minnesota. His patients come from all walks of life. When he is not enjoying time with his family he devotes much of his time to research in the fields of neurology, functional medicine, functional nutrition, cellular healing, cellular toxicity, and genetics. DR. LARSEN’S BLOG: http://drlarsen.com/blog FACEBOOK: http://facebook.com/LarsenWellnessCenter YOUTUBE: https://youtube.com/c/DrLarsen DR. LARSEN’S CLINIC: http://LarsenWellnessCenter.com DR. LARSEN’S SHOP: http://ShopLarsenWellness.com Larsen Wellness Center 146 North Lake St., Suite 220 Forest Lake, MN 55025 651-982-1804 DISTANCE PATIENT PROTOCOL: Dr. Larsen works with distance patients all over the world via Skype (and/or telephone in the U.S.). If you are interested in working with him, please call his office at 651.982.1804 or email his staff at: firstname.lastname@example.org. Due to his demanding schedule Dr. Larsen only accepts a very limited number of distance patients. Please note that applying to become a patient in his clinic does not automatically mean acceptance. After the consultation, Dr. Larsen will review all of the information and he will decide if he will accept your case. Dr. Larsen only accepts those cases that he truly feels that he can help! DISCLAIMER: Dr. Larsen does not diagnose, treat or prevent any medical conditions; instead he helps PEOPLE who may or may not have named and blamed conditions. All of the material on this video is intended as educational information only in regards to alternative healthcare options that are available to the healthcare consumer. The advice on this site and in all of Dr. Brant Larsen’s published works are intended solely for informational and educational purposes and are NOT intended to replace your doctor. The FDA has stated that only medications (drugs) can cure an illness or disease. The statements on this site have not been evaluated by the FDA and the products available on this site are not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional if you have questions about your health. The information provided on this site and in his publications is intended to help you, help yourself.
Просмотров: 6863 Dr. Brant Larsen
Thyroid Cancer: Radioactive Iodine Pill Process. It was a long day at the hospital, so that my wife could start her treatment. Back and forth through the hospital campus, from getting her scan then to see the oncologist. Once that was all done, after talking with the doctor it was time to take the pill. It was a lot, yet in the end its all worth it. Life is worth it, you are worth it. Take the time for you. Blessings. Thank you all for the Love and Support. It has been great to have the Prayers, the comments, the gifts. The giving of your time is truly Appreciated. BLENDED CHAOS PO BOX 15416 FT WAYNE IN 46885
Просмотров: 3298 Blended Chaos
A new gene test may help identify slow-growing prostate cancers that will require treatment, a new study suggests. The test revealed the levels of "expression" of three aging-related genes and could be used to predict whether seemingly slow-growing prostate cancer will remain slow-growing, according to Columbia University Medical Center researchers. Using the three-gene test along with existing cancer-staging tests could help doctors better determine which men with early prostate cancer can be safely monitored and spared the potential risks of prostate removal or other invasive treatments, the study authors suggested. The investigators assessed the test in 43 prostate cancer patients who had been monitored for at least 10 years. All of the men had initially been diagnosed with low-risk cancer, but 14 eventually developed advanced prostate cancer. All 14 of those patients were correctly identified by the three-gene test, according to the study, which was published online Sept. 11 in the journal Science Translational Medicine. The researchers plan to conduct a larger study to assess the test's accuracy. "Most of the 200,000 prostate cancers diagnosed each year in the U.S. are slow-growing and will remain so, but the three-gene biomarker could take much of the guesswork out of the diagnostic process and ensure that patients are neither overtreated nor undertreated," study leader Cory Abate-Shen, a professor of urological oncology at Columbia University Medical Center, said in a university news release. And, as study co-author Dr. Mitchell Benson, chairman and professor of urology at the medical center, explained in the news release: "The problem with existing tests is that we cannot identify the small percentage of slow-growing tumors that will eventually become aggressive and spread beyond the prostate." Currently, men diagnosed with low-risk prostate cancer can choose either active surveillance, which includes regular testing and monitoring but risks missing the window when the disease is localized and potentially curable, or aggressive treatment, which can cause serious side effects such as urinary incontinence and impotence. Dr. Louis Kavoussi is chairman of urology at North Shore-LIJ's Arthur Smith Institute for Urology in New Hyde Park, N.Y. He said: "Men getting a diagnosis of prostate cancer are initially shocked and begin conjuring images of themselves as desperate, dying patients. In reality, the majority of patients with prostate cancer do not die of the disease, and a large portion can be managed with observation. This study looks at novel molecular tools to help define which patients can be managed conservatively, and avoid potential side effects and expensive treatments." Dr. Aaron Katz, chairman of urology at Winthrop-University Hospital in Mineola, N.Y., said: "In the current era, it is clear that PSA screening has detected many men with prostate cancer. In the years past, we believed that all men needed to be treated. The good news is that many men who are found to have these abnormal cells in their prostate may not need any treatment. With advances in genomics and DNA testing, we are now able to stratify those men with indolent disease, and prevent unnecessary treatment."
Просмотров: 383 Heath and Beauty
To learn more about cancer genetic testing or to schedule an appointment, visit https://wexnermedical.osu.edu/genetics or call 614-293-6694. Cowden Syndrome is a rare hereditary cancer syndrome causing increased risk of cancers including breast, endometrial, colon, renal and melanoma. Peter Stanich, MD, a gastroenterologist at The Ohio State University Wexner Medical Center encourages those who are concerned they might have Cowden Syndrome or other genetic risks for cancer to consider genetic screening at Ohio State. If a genetic connection is discovered, patient risk of cancer can be reduced through increased screening and surveillance. Cancer. To learn more or to schedule a gastroenterology appointment, visit https://internalmedicine.osu.edu/digestivediseases/ or call (614) 293-6255
Просмотров: 1052 Ohio State Wexner Medical Center
Cancer genetic counselor Kimberly Banks talks about the methods used for genetic testing. Different models are used to calculate the risk for breast cancer. Click Here & Get The 15 Breast Cancer Questions To Ask Your Doctor http://www.breastcanceranswers.com/what-breast-cancer-questions-to-ask/# Breast Cancer Answers is a social media show where viewers submit a question and get the answer from an expert. Submit your question now at, http://www.breastcanceranswers.com/ask. This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.
Просмотров: 2616 Breast Cancer Answers®
Kathryn Ruddy, MD, associate professor of Oncology, Mayo Clinic, discusses how genetic testing could impact treatment of patients with breast cancer. According to Ruddy, it’s important to perform genetic testing for genes like BRCA1 and BRCA2, which have already been determined to play a role in care of women with strong family history of breast cancer or younger patients. Because rates of these mutations are higher in younger women diagnosed with breast cancer, it is best to do genetic testing early as it can impact surgical treatment decisions. It can also be useful in metastatic disease where PARP inhibitors are more effective in patients with BRCA mutations. Ruddy says that even though a patient here may not undergo breast surgery, understanding the mutations can still play a role in selecting systemic therapies.
Просмотров: 87 OncLiveTV
Heard of MTHF or Genetic Mutations? How About Heavy Metal toxicities or Food Sensitivities? Sufferers of Thyroid Dysfunction MUST know about these if they ever want to heal the thyroid. Perhaps these are contributing to a thyroid problem resulting in fatigue, brain fog, difficulty losing weight, feeling cold all the time, insomnia, GI disturbances and many other problems experienced by thyroid sufferers. My name is Dr. Joel Rosen DC, and I am a Certified Functional Medicine Practitioner, that incorporates genetic testing and specific genetic support protocol that will help heal the thyroid....naturally. We are currently offering the first 10 callers a complete neurology examination as well as a complete functional laboratory evaluation to determine if they are a good candidate for genetic testing/support to help heal the thyroid problem. Regular price is $450, but for a limited number of people (the first 10 callers) we will do all of the above for $75 dollars. We are located in Boca Raton Florida. Call us now at 561-883-0090 to be one of the first 10. Sincerely, Dr. Joel Rosen DC, CFMP, DAAIM, The patient and any other person responsible for payment has a right to refuse to pay, cancel payment, or be reimbursed for payment for any service, examination, or treatment that is performed as a result and within 72 hours of responding to the advertisement for the free, discounted fee, or reduced fee service, examination or treatment.
Просмотров: 132 doctorjoelrosen